Skip to main content

Advertisement

SpringerLink
Log in

Treatment with an oral fluoropyrimidine, S-1, plus cisplatin in patients who failed postoperative gemcitabine treatment for pancreatic cancer: a pilot study

  • ORIGINAL ARTICLE
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

This study set out to evaluate, in patients with gemcitabine-resistant pancreatic cancer, the response rate and toxicity of S-1 plus cisplatin (CDDP).

Methods

Seventeen patients with histologically diagnosed invasive ductal pancreatic cancer were enrolled in this study. All patients had growing recurrent pancreas cancer despite the administration of gemcitabine. Thirteen patients underwent pancreatectomy, and 2 underwent choledochojejunostomy and gastrojejunostomy without pancreatectomy. S-1 (80 mg/m2 per day) was orally administered for 21 consecutive days, followed by a 14-day rest period. CDDP (40 mg/m2) in 500 ml saline was administered by intravenous drip on day 8. This schedule was repeated every 5 weeks until the occurrence of disease progression, unacceptable toxicities, or the patient's refusal to continue.

Results

Five (29.4%) patients achieved a partial response and 2 (11.8%) had stable disease. In 5 of 15 patients (33.3%) who had elevated serum carbohydrate antigen (CA)19-9 levels at the start of treatment the CA19-9 was reduced by more than 50%. The median survival time was 10 months (range, 20 months), with 63.7% and 31.9% of patients alive at 6 and 12 months, respectively. Major adverse reactions in the 15 patients included gastrointestinal toxicities of grade 1 or 2. Only one patient (5.9%) developed grade 3 leucopenia.

Conclusion

S-1 with CDDP has a promising effect against gemcitabine-resistant pancreatic cancer, with easily manageable toxicities. Further investigation of this regimen is warranted in patients with pancreatic cancer, especially in comparison with gemcitabine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. B Gudjonsson (1987) ArticleTitleCancer of the pancreas: 50 years of surgery Cancer 60 2284–2303 Occurrence Handle3326653 Occurrence Handle10.1002/1097-0142(19871101)60:9<2284::AID-CNCR2820600930>3.0.CO;2-V Occurrence Handle1:STN:280:DyaL1c7ltVKrtA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  2. M Trede G Schwall HD Saeger (1990) ArticleTitleSurvival after pancreatoduodenectomy: 118 consecutive resections without an operative mortality Ann Surg 211 447–458 Occurrence Handle2322039 Occurrence Handle10.1097/00000658-199004000-00011 Occurrence Handle1:STN:280:DyaK3c3htVOgug%3D%3D

    Article  PubMed  CAS  Google Scholar 

  3. RJ Geer MF Brenman (1993) ArticleTitlePrognostic indicators for survival after resection of pancreatic adenocarcinoma Am J Surg 165 68–73 Occurrence Handle8380315 Occurrence Handle10.1016/S0002-9610(05)80406-4 Occurrence Handle1:STN:280:DyaK3s7hvVynsQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  4. SS Nitecki MG Sarr TV Colby et al. (1995) ArticleTitleLong-term survival after resection for ductal adenocarcinoma of the pancreas Ann Surg 211 59–66 Occurrence Handle10.1097/00000658-199501000-00007

    Article  Google Scholar 

  5. MH Kalser SS Ellenberg (1985) ArticleTitlePancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection Arch Surg 120 899–903 Occurrence Handle4015380 Occurrence Handle1:STN:280:DyaL2M3ltFSnsQ%3D%3D

    PubMed  CAS  Google Scholar 

  6. S Cullinan CG Moertel HS Wieand et al. (1990) ArticleTitleA phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin Cancer 65 2207–2212 Occurrence Handle2189551 Occurrence Handle10.1002/1097-0142(19900515)65:10<2207::AID-CNCR2820651007>3.0.CO;2-Y Occurrence Handle1:STN:280:DyaK3c3mvVertw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  7. D Kelsen C Hudis D Niedzwiecki et al. (1991) ArticleTitleA phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma Cancer 68 965–969 Occurrence Handle1833042 Occurrence Handle10.1002/1097-0142(19910901)68:5<965::AID-CNCR2820680509>3.0.CO;2-2 Occurrence Handle1:STN:280:DyaK38%2FgsFahtA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  8. J Crown ES Casper J Botet et al. (1991) ArticleTitleLack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma J Clin Oncol 9 1682–1686 Occurrence Handle1875224 Occurrence Handle1:STN:280:DyaK3MzktFGgtA%3D%3D

    PubMed  CAS  Google Scholar 

  9. JR Hecht R Bedford JL Abbruzzese et al. (2003) ArticleTitleA phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma Clin Cancer Res 9 555–561 Occurrence Handle12576418 Occurrence Handle1:CAS:528:DC%2BD3sXhtVKksr0%3D

    PubMed  CAS  Google Scholar 

  10. JH Klinkenbijl J Jeekel T Sahmoud et al. (1999) ArticleTitleAdjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group Ann Surg 230 776–782 Occurrence Handle10615932 Occurrence Handle10.1097/00000658-199912000-00006 Occurrence Handle1:STN:280:DC%2BD3c%2FotFKkug%3D%3D

    Article  PubMed  CAS  Google Scholar 

  11. M Huguier A Barrier R Valinas et al. (2001) ArticleTitleFrench University Association for Surgical Research. Randomized trial of 5-fluorouracil, leucovorin and cisplatin in advanced pancreatic cancer Hepatogastroenterology 48 875–878 Occurrence Handle11462946 Occurrence Handle1:CAS:528:DC%2BD3MXlt12nsL4%3D

    PubMed  CAS  Google Scholar 

  12. ML Rothenberg JK Benedetti JS Macdonald et al. (2002) ArticleTitlePhase II trial of 5-fluorouracil plus eniluracil in patients with advanced pancreatic cancer: a Southwest Oncology Group study Ann Oncol 13 1576–1582 Occurrence Handle12377645 Occurrence Handle10.1093/annonc/mdf274 Occurrence Handle1:STN:280:DC%2BD38nitVWruw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  13. M Ducreux P Rougier JP Pignon et al. (2002) ArticleTitleGroupe Digestif of the Federation Nationale des Centres de Lutte Contre le Cancer Digestif. A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma Ann Oncol 13 1185–1191 Occurrence Handle12181240 Occurrence Handle10.1093/annonc/mdf197 Occurrence Handle1:STN:280:DC%2BD38visVertA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  14. HA Burris SuffixIII MJ Moore J Andersen et al. (1997) ArticleTitleImprovements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial J Clin Oncol 15 2403–2413 Occurrence Handle9196156 Occurrence Handle1:CAS:528:DyaK2sXlsFKksLY%3D

    PubMed  CAS  Google Scholar 

  15. C Louvet R Labianca P Hammel et al. (2005) ArticleTitleGemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: result of a GERCOR and GISCAD phase III trial J Clin Oncol 23 3509–3516 Occurrence Handle15908661 Occurrence Handle10.1200/JCO.2005.06.023 Occurrence Handle1:CAS:528:DC%2BD2MXlsVyhsrg%3D

    Article  PubMed  CAS  Google Scholar 

  16. MJ Moore J Hamm J Dancey et al. (2003) ArticleTitleComparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of National Cancer Institute of Canada Clinical Trial Group J Clin Oncol 21 3296–3302 Occurrence Handle12947065 Occurrence Handle10.1200/JCO.2003.02.098 Occurrence Handle1:CAS:528:DC%2BD2cXps1akurs%3D

    Article  PubMed  CAS  Google Scholar 

  17. K Tatsumi M Fukushima T Shirasaka et al. (1987) ArticleTitleInhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rat liver extracts Jpn J Cancer Res 78 748–755 Occurrence Handle3114201 Occurrence Handle1:CAS:528:DyaL2sXlvFSntL8%3D

    PubMed  CAS  Google Scholar 

  18. T Shirasaka K Nakano T Takechi et al. (1996) ArticleTitleAntitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats Cancer Res 56 2602–2606 Occurrence Handle8653704 Occurrence Handle1:CAS:528:DyaK28XjtlCgurg%3D

    PubMed  CAS  Google Scholar 

  19. T Shirasaka Y Shimamato H Ohshimo et al. (1996) ArticleTitleDevelopment of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators Anticancer Drugs 7 548–757 Occurrence Handle8862723 Occurrence Handle10.1097/00001813-199607000-00010 Occurrence Handle1:CAS:528:DyaK28Xltleru78%3D

    Article  PubMed  CAS  Google Scholar 

  20. Y Sakata A Ohtsu N Horikoshi et al. (1998) ArticleTitleLate phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients Eur J Cancer 34 1715–1720 Occurrence Handle9893658 Occurrence Handle10.1016/S0959-8049(98)00211-1 Occurrence Handle1:CAS:528:DyaK1cXntlShurw%3D

    Article  PubMed  CAS  Google Scholar 

  21. CJ Van Groeningen GJ Peters JH Schornagel et al. (2000) ArticleTitlePhase I clinical and pharmacokinetic study of oral S-1 in patients with advanced solid tumors J Clin Oncol 18 2772–2779 Occurrence Handle10894878 Occurrence Handle1:CAS:528:DC%2BD3cXls12hsr4%3D

    PubMed  CAS  Google Scholar 

  22. K Hayashi T Imaizumi K Uchida et al. (2002) ArticleTitleHigh response rates in patients with pancreatic cancer using the novel oral fluoropyrimidine S-1 Oncol Rep 9 1355–1361 Occurrence Handle12375048 Occurrence Handle1:CAS:528:DC%2BD38XosFSrtbo%3D

    PubMed  CAS  Google Scholar 

  23. T Brodowicz RM Wolfram WJ Kostler et al. (2000) ArticleTitlePhase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer Anticancer Drugs 11 623–628 Occurrence Handle11081453 Occurrence Handle10.1097/00001813-200009000-00004 Occurrence Handle1:CAS:528:DC%2BD3cXnsl2gsro%3D

    Article  PubMed  CAS  Google Scholar 

  24. PA Philip MM Zalupski VK Vaitkevicius et al. (2001) ArticleTitlePhase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma Cancer 92 569–577 Occurrence Handle11505401 Occurrence Handle10.1002/1097-0142(20010801)92:3<569::AID-CNCR1356>3.0.CO;2-D Occurrence Handle1:CAS:528:DC%2BD3MXmsVyjtLw%3D

    Article  PubMed  CAS  Google Scholar 

  25. Z Symon M Davis CJ McGinn et al. (2002) ArticleTitleConcurrent chemoradiotherapy with gemcitabine and cisplatin for pancreatic cancer: from the laboratory to the clinic Int. J Radiat Oncol Biol Phys 53 140–145 Occurrence Handle12007952 Occurrence Handle10.1016/S0360-3016(01)02790-0 Occurrence Handle1:CAS:528:DC%2BD38Xjtl2hur4%3D

    Article  PubMed  CAS  Google Scholar 

  26. G Colucci F Giuliani V Gebbia et al. (2002) ArticleTitleGemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale Cancer 94 902–910 Occurrence Handle11920457 Occurrence Handle10.1002/cncr.10323 Occurrence Handle1:CAS:528:DC%2BD38XitVKhs74%3D

    Article  PubMed  CAS  Google Scholar 

  27. JP Neoptolemos DD Stocken H Friess et al. (2004) ArticleTitleEuropean Study Group for Pancreatic Cancer. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 1200–1210 Occurrence Handle15028824 Occurrence Handle10.1056/NEJMoa032295 Occurrence Handle1:CAS:528:DC%2BD2cXit12rtr8%3D

    Article  PubMed  CAS  Google Scholar 

  28. T Okusaka T Kosuge (2004) ArticleTitleSystemic chemotherapy for pancreatic cancer Pancreas 28 301–304 Occurrence Handle15084976 Occurrence Handle10.1097/00006676-200404000-00017 Occurrence Handle1:CAS:528:DC%2BD2cXjslCnt7Y%3D

    Article  PubMed  CAS  Google Scholar 

  29. W Koizumi S Tanabe K Saigenji et al. (2003) ArticleTitlePhase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer Br J Cancer 89 2207–2212 Occurrence Handle14676796 Occurrence Handle10.1038/sj.bjc.6601413 Occurrence Handle1:CAS:528:DC%2BD3sXpvVShtbc%3D

    Article  PubMed  CAS  Google Scholar 

  30. A Togawa H Ito F Kimura et al. (2003) ArticleTitleEstablishment of gemcitabine-resistant human pancreatic cancer cells and effect of brefeldin-A on the resistant cell line Pancreas 27 220–224 Occurrence Handle14508125 Occurrence Handle10.1097/00006676-200310000-00004 Occurrence Handle1:CAS:528:DC%2BD2cXks1yisw%3D%3D

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba, 260-0856, Japan

    Akira Togawa, Hideyuki Yoshitomi, Hiroshi Ito, Fumio Kimura, Hiroaki Shimizu, Masayuki Ohtsuka, Hiroyuki Yoshidome, Atsushi Kato, Shigeaki Sawada & Masaru Miyazaki

Authors
  1. Akira Togawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hideyuki Yoshitomi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hiroshi Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fumio Kimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiroaki Shimizu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masayuki Ohtsuka
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hiroyuki Yoshidome
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Atsushi Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Shigeaki Sawada
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Masaru Miyazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masaru Miyazaki.

About this article

Cite this article

Togawa, A., Yoshitomi, H., Ito, H. et al. Treatment with an oral fluoropyrimidine, S-1, plus cisplatin in patients who failed postoperative gemcitabine treatment for pancreatic cancer: a pilot study. Int J Clin Oncol 12, 268–273 (2007). https://doi.org/10.1007/s10147-007-0674-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-007-0674-x

Key words

Search

Navigation